Abivax S.A. (0RA9.L) LSE
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.27B |
| Enterprise Value | 7.79B |
| P/E Ratio | -17.8 |
| PEG Ratio | 0.32 |
| Price/Sales Ratio | -3,623.41 |
| Price/Book Ratio | 18.23 |
| Enterprise/Revenue | -3,431.65 |
| Enterprise/EBITDA | -24.87 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 174.89 |
| Operating Margin | 119.5 |
AD
Management Effectiveness
| Return On Assets | -0.76 |
| Return On Equity | -0.86 |
Income Statement
| Revenue | 0 |
| Revenue/Share | -0.03 |
| Gross Profit | -1.07M |
| EBITDA | -249.55M |
| Net Income | -336.1M |
| Diluted EPS | -4.83 |
Balance Sheet
| Total Cash | 530.38M |
| Total Cash/Share | 5.16 |
| Total Debt | 32.09M |
| Total Debt/Equity | 0 |
| Current Ratio | 5.97 |
| Book Value Per Share | 4.6 |
Price History
| 52-Week Change | 17.18 |
| 52-Week High | 139 |
| 52-Week Low | 5.68 |
| Moving Average 50 Days | 11.44 |
| Moving Average 200 Days | 13.25 |
Statistics
| Average Volume | 5,413 |
| Shares Outstanding | 79.3M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
